Lumos Pharma Inc
NASDAQ:LUMO 4:00:00 PM EDT
Market Cap (Intraday) | 22.86M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $2.84 |
50-Day MA | $2.94 |
200-Day MA | $3.21 |
Lumos Pharma Inc Stock, NASDAQ:LUMO
4200 Marathon Boulevard, Suite 200, Austin, Texas 78756
United States of America
Phone: +1.512.215.2630
Number of Employees: 33
Description
Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for rare diseases. Its product includes LUM-201, an oral growth hormone stimulating small molecule for the treatment of pediatric growth hormone deficiency (PGHD). The company was founded on June 4, 1999 and is headquartered in Austin, TX.